Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Reiterates Overweight Rating on Vaxcyte (PCVX), VAX-24 Study Patient Dosing Brings the Company Closer to Potential Commercialization
-
Vaxcyte (PCVX) VAX-24 Data Underscores 'Best In Class Potential' - Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Vaxcyte (PCVX) at Overweight
